Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,000 | <0.01 | Reduce 23.76% | <0.01 | $195.98 | $587,940 | SEC |
| 2025 Q4 | 3,935 | <0.01 | Add 2.61% | $173.53 | $682,841 | SEC | |
| 2025 Q3 | 3,835 | <0.01 | Reduce 32.68% | <0.01 | $190.58 | $730,874 | SEC |
| 2025 Q2 | 5,697 | <0.01 | Add 2.67% | <0.01 | $179.63 | $1,023,353 | SEC |
| 2025 Q1 | 5,549 | <0.01 | Add 12.12% | <0.01 | $169.20 | $938,891 | SEC |
| 2024 Q4 | 4,949 | <0.01 | $150.86 | $746,606 | SEC | ||
| 2024 Q3 | 4,949 | <0.01 | Add 11.24% | <0.01 | $155.25 | $768,333 | SEC |
| 2024 Q2 | 4,449 | <0.01 | Add 15.59% | <0.01 | $136.88 | $608,979 | SEC |
| 2024 Q1 | 3,849 | <0.01 | $133.11 | $512,341 | SEC | ||
| 2023 Q4 | 3,849 | <0.01 | $137.88 | $530,700 | SEC | ||
| 2023 Q3 | 3,849 | <0.01 | Add 4.85% | <0.01 | $121.86 | $469,039 | SEC |
| 2023 Q2 | 3,671 | <0.01 | $140.56 | $515,996 | SEC | ||
| 2023 Q1 | 3,671 | <0.01 | Add 1,239.78% | <0.01 | $141.48 | $519,373 | SEC |
| 2022 Q4 | 274 | <0.01 | Reduce 8.36% | $156.44 | $42,865 | SEC | |
| 2022 Q3 | 299 | <0.01 | Add 128.24% | <0.01 | $123.75 | $37,000 | SEC |
| 2022 Q2 | 131 | 0.00 | $129.77 | $17,000 | SEC | ||
| 2022 Q1 | 131 | 0.00 | Buy | $137.40 | $18,000 | SEC |